L.A. Area Hospitals Join Clinical Study on Potential COVID-19 Treatment - PIH Health

Skip to Content

Published on April 15, 2020

L.A. Area Hospitals Join Clinical Study on Potential COVID-19 Treatment

MyNewsLa.com – PIH Health Whittier Hospital is among 46 hospitals worldwide that are participating in a clinical study to provide an antiviral medication, Remdesivir (RDV), as a potential treatment for the coronavirus.

Other L.A. area hospitals participating in the study include MemorialCare Long Beach Medical Center and Huntington Hospital in Pasadena.

Remdesivir was initially developed by Gilead Sciences for the treatment of disease related to two other viruses including Ebola, but is now part of an international, multi-center clinical study to determine if it is safe and effective in treating patients with COVID-19.